Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Mar 17;16(3):e0247575. doi: 10.1371/journal.pone.0247575

Development, manufacturing, and preliminary validation of a reusable half-face respirator during the COVID-19 pandemic

Vahid Anwari 1,2,#, William C K Ng 3,4,5,*,#, Arnaud Romeo Mbadjeu Hondjeu 4,#, Zixuan Xiao 6,, Edem Afenu 7,8,, Jessica Trac 8,, Kate Kazlovich 2,9,, Joshua Hiansen 2,, Azad Mashari 2,3,4,#
Editor: Tommaso Lomonaco10
PMCID: PMC7968700  PMID: 33730106

Abstract

Introduction

The COVID-19 pandemic has led to widespread shortages of N95 respirators and other personal protective equipment (PPE). An effective, reusable, locally-manufactured respirator can mitigate this problem. We describe the development, manufacture, and preliminary testing of an open-hardware-licensed device, the “simple silicone mask” (SSM).

Methods

A multidisciplinary team developed a reusable silicone half facepiece respirator over 9 prototype iterations. The manufacturing process consisted of 3D printing and silicone casting. Prototypes were assessed for comfort and breathability. Filtration was assessed by user seal checks and quantitative fit-testing according to CSA Z94.4–18.

Results

The respirator originally included a cartridge for holding filter material; this was modified to connect to standard heat-moisture exchange (HME) filters (N95 or greater) after the cartridge showed poor filtration performance due to flow acceleration around the filter edges, which was exacerbated by high filter resistance. All 8 HME-based iterations provided an adequate seal by user seal checks and achieved a pass rate of 87.5% (N = 8) on quantitative testing, with all failures occurring in the first iteration. The overall median fit-factor was 1662 (100 = pass). Estimated unit cost for a production run of 1000 using distributed manufacturing techniques is CAD $15 in materials and 20 minutes of labor.

Conclusion

Small-scale manufacturing of an effective, reusable N95 respirator during a pandemic is feasible and cost-effective. Required quantities of reusables are more predictable and less vulnerable to supply chain disruption than disposables. With further evaluation, such devices may be an alternative to disposable respirators during public health emergencies. The respirator described above is an investigational device and requires further evaluation and regulatory requirements before clinical deployment. The authors and affiliates do not endorse the use of this device at present.

Introduction

The COVID-19 pandemic has unveiled widespread shortages of N95 respirators worldwide. In fact, all threats of pandemic disease in the last 20 years have resulted in either local or global shortages of disposable N95s [1, 2]. This latest pandemic has once again highlighted the inadequacy of existing strategies for pandemic respiratory protection planning [3]. A 2015 modeling study done jointly by the National Center for Immunization and Respiratory Diseases and the Office of Infectious Diseases, Centers for Disease Control and Prevention (CDC) in the United States [4] estimated that a respiratory pandemic affecting 20–30% of the US population would require between 1.7 and 7.3 billion disposable respirator masks, more than 30 times the total national holdings in the US at the time. Other studies have reached similar conclusions and their predictions have been largely borne out by the current pandemic [5, 6].

Health care workers (HCWs) face hazardous occupational exposures to infectious organisms, many of which are spread through airborne or aerosol routes [5]. To minimize risk of infection when treating patients with COVID-19, the CDC recommends the use of personal protective equipment (PPE) including gown, gloves, N95 respirator, and a face-shield or goggles. Paramount to emergency preparation is accessibility of PPE, particularly respiratory protective devices (RPDs). RPDs and other PPE are the last line of defense when exposures cannot be reduced to an acceptable level using other control methods [7]. Disposable N95 filtering face-piece respirators are currently the most commonly used devices to protect HCWs [8]. These respirators are designed to create a seal on the face and, when sealed, remove at least 95% of airborne particles of size around 0.3 um (the most penetrating particle size) [9, 10].

In the long run, addressing the failures of respiratory protection strategies will require a holistic, systems-based approach of which technical innovations in respirator design and production will be only a part. In the midst of the crisis however, technical innovation is often the most accessible point of intervention for addressing acute local needs. We describe the development, manufacturing process and initial performance evaluation of a reusable N95 respirator, referred to as SSM (“Simple Silicone Mask”) hereafter, that can be manufactured on-site, using distributed manufacturing technologies. Such reusable, locally manufacturable devices are far less vulnerable to sudden surges in demand and supply chain disruptions that accompany global pandemics. The device took inspiration from open-source designs and was developed through the collaboration of physicians, engineers, researchers, students, and private sector partners. It is licensed under a CERN Open Hardware Version 2-Strongly Reciprocal license, which permits modification and production of the device without specific permission, including for industrial manufacturing, commercial distribution and sale.

Methods

Model 1: Rigid 3D-printable mask with filter cartridge

Our design process began with the “Stop-Gap Face Mask (SFM)” (Fig 1) an open-source licensed design by Chris Richburg available through the National Institutes of Health’s 3D Print Exchange (https://3dprint.nih.gov/discover/3dpx-013429). This mask consists of a rigid 3D-printable body with a built-in cartridge frame designs to hold flat sheets of filter material. High-resolution prototypes were created using PolyJet printing on the Stratasys® J750 Digital Anatomy™ using Digital ABS Plus resin. Based on a review of scientific and lay literature, discussions with material science experts and industry partners, as well as product availability during the current pandemic, the following materials were selected for testing: 5N11 (3M, Maplewood, MN, USA) and H400 (Halyard Health, Alpharetta, GA, USA).

Fig 1. Initial respirator design “SFM” with a sample of the filter material in the single layer cartridge configuration.

Fig 1

A sample of each filter material measuring 5 cm2 (effective surface area ~ 16 cm2; 0.5–1.0 mm thick) was fitted onto the SFM filter cartridge holder. The respirator was attached to a test fixture and sealed with aluminum tape (Figs 2 and 3). Samples were tested at a flow of 30 +/- 4 L/min using 2% sodium chloride solution in distilled water (NaCl), according to US Government 42 Code of Federal Regulations (CFR) Part 84 Test for RPD [11, 12]. This regulation on respiratory protection equipment is informed by the research and guidance by the National Institute for Occupational Safety and Health (NIOSH). The test sequentially measures the filtration of 10–400 nm NaCl particles. General purpose health care respirators must achieve 95% filtration of particles around 0.3 um [10]. Particle count (count / cm3) and resistance (kPa) around mask and filter seal were measured.

Fig 2. In-profile representation of the SFM respirator assembled on a fixture housed in the exposure chamber for filtration efficiency testing.

Fig 2

Fig 3. Schematic of preliminary filtration efficiency testing [13].

Fig 3

FFR stands for face filtering respirator. EC 3080 is an electrostatic classifier and CPC 3785 a condensation particle counter.

The filter-cartridge design showed very poor filtration performance (see Table 1), regardless of the filter materials used. Failure was largely due to the inability to create a reliable seal around the removable filter within the filter-cartridge, despite several revisions of the design. In addition, the 3D printed body was unlikely to be comfortable for long wear and required significant print time for each unit.

Table 1. Preliminary testing of filtration systems (42 CFR Part 84 (30 L/min)).

System Seal Resistance (kPa) Expected (kPa) Particles passed (count/cm3) * Flow constant (L/min)
Mask Filter
SFM 3M 5N11–2 ply -1.3 < -250 1288 30 +/- 4
SFM 3M 5N11–2 ply -1.0 < -250 2040 30 +/- 4
SFM 3M 5N11–3 ply -2.5 < -250 3495 30 +/- 4
Sewn Mask Halyard H400–2 ply -4.2 < -250 271 30 +/- 4

†The expected seal resistance is negative, with < -250 kPa indicating an adequate seal.

*The no. of particles passing through in an ideal filtration system is < 20 per cubic cm in volume.

The filter-cartridge style design was thus abandoned, in favor of masks connected directly to off-the-shelf Heat and Moisture Exchange (HME) filters with known filtration efficiency and pressure drop properties. The team then moved on to a model 2, using silicone for the mask body that incorporates an HME filter.

Model 2: Silicone mask cast from 3D-printed mold connected to off-the-shelf HME filter

The starting point for the final SSM design was the Simple Silicone Respirator (SSR) designed by Dr. Christian Petropolis at the University of Manitoba. The SSR was cast from 3D printed molds, which allowed use of a wider range of materials than direct 3D printing and also permitted more rapid scale-up of production for the final design.

At each design iteration, the device and corresponding mold designs were modified using computer-aided design (CAD) software (Onshape, www.onshape.com; and Fusion 360TM, Autodesk®). The final 4-part mold design is shown in Fig 4.

Fig 4.

Fig 4

The final design of each mold part is shown; (a) base, (b) middle, (c) top cover with left and right halves.

Each part was exported from the CAD software as a stereolithography (STL) file and prepared for 3D printing using the PrusaSlicer (v. 2.2.0) software. Molds were printed on Prusa I3 MK3S (Prusa Research, Prague, Czech Republic) 3D printers with a 0.4 mm nozzle using PLA (polylactic acid) or PETG (polyethylene terephthalate glycol); Figs 57 depicts the mold parts.

Fig 5. 3D printed mold base is shown.

Fig 5

Fig 7. 3D printed mold top cover left and right halves with a pour hole for silicone is shown.

Fig 7

Fig 6. 3D printed mold middle component is shown.

Fig 6

To secure the mask to the face, a harness was designed and printed. Figs 8 and 9 represents the harness. The STL files for the molds and harness are available at our project repository at https://github.com/tgh-apil/Reusable-N95-Respirator.

Fig 8. Design of the final model for the harness with holes for elastic strap attachment.

Fig 8

Fig 9. 3D printed harness using PET-G plastic on the Prusa-MK3.

Fig 9

To make the respirator body, the 3D printed molds from Figs 57 were assembled for silicone pouring (Fig 10). A 2-part biocompatible casting silicone (Dragon Skin™20, Smooth-on, Macungie, PA, USA) [14] was poured into the assembled mold from the pour hole shown in Fig 7. The mold was then allowed to cure for over 4 hours. A step-by-step process for preparing and casting the silicone mold is provided in S1 File.

Fig 10.

Fig 10

a) Assembled 4-part mold b) Silicone pouring into molds. (a) The 4-part printed mold is shown assembled using two screws. The two-halves of the cover were glued for sealing. (b). Silicone was poured from a high distance to eliminate bubble formation in the mold.

The final device consisted of the silicone mask, HME filter, a harness and 2 elastic straps (6.4 mm x 50 cm) attached to the harness. The fully assembled respirator is shown in Figs 1113. The final cured silicone was soft to the touch, elastic and provided an air-tight seal while worn on the face. The complete mask weighed 234 g. The cost breakdown for the first respirator model is shown in Table 2. Not included in this cost is the price of using a 3D printer such as the Prusa™MK3, which costs approximately CAD $1000. The molds can be reused to make additional units.

Fig 11. Silicone mask body with harness and Intersurgical Air-Guard™ pictured.

Fig 11

Fig 13. Assembled SSM respirator mask.

Fig 13

Table 2. Material costs and components required for a single respirator.

Component Material Amount of material (g) Cost/unit (CAD) Development Time (h)*
Mold Part 1 Base PET G filament 94.1 2.4 8
Mold Part 2 Middle PET G filament 122 3.0 12
Mold Part 3 Cover (left and right) PETG filament 118 2.8 13
Harness PETG filament 18.5 0.5 3
Respirator body Silicone 155 11.6 1
Inter-surgical Air Guard Filter HEPA N100 rated filter 56 3.6 n/a
Elastic strap (64 mm wide) Polyester and natural latex rubber 100 0.3 0.08

* Development time of the mold and harness are the initial print times; when referred to the body, it is the silicone set-time. Labor time referred to in the abstract is the human hands-on time for pouring the silicone and assembly of the SSM.

Fig 12. Inside of the silicone mask body.

Fig 12

The prototype respirator with the HME filter as shown in Fig 13 was initially tested on three of the authors (VA, WN, AM) by wearing it for 30–60 min to evaluate basic comfort and usability. Negative seal-pressure checks, by occluding the filter, and positive seal pressure checks were done to identify location of seal defects. The design was iteratively modified and tested over 8 weeks, that is the SSM was gradually remodeled with three major iterations. Once a prototype passed these qualitative assessments, preliminary quantitative fit-tests (QNFT) were performed to assess the “fit-factors” per CSA Z94.4–18 protocol using an AccuFIT™ 9000 Fit-tester Machine (Levitt-Safety, Oakville, Canada) [15]. The subject dons the respirator and is required to perform seven sequential maneuvers: normal breathing, deep breathing, turning head side-to-side, nodding, talking, bending over, and repeated normal breathing. The fit-testing device simultaneously measures the particle concentration in ambient room air as well as the concentration inside the respirator and calculates a “fit-factor” as the unitless ratio of the outside (ambient room) to inside (respirator) concentration integrals over time. For each of the seven maneuvers, an individual fit-factor of over 100 is defined as a component pass according to CSA Z94.4–18. An overall fit-factor of over 100 is also required for an overall pass for that respirator-fitting according to CSA Z94.4–18. The overall fit-factor of the seven maneuvers is the harmonic mean of the seven runs, given by:

OverallFit-Factor=No.Runs(N)/(1/ff1+1/ff2+1/ff3++1/ffN),

where N = 7 for QNFT per CSA Z94.4–18 [16].

The QNFT testing study protocol was approved by the University Health Network Research Ethics Board, Toronto (REB # 20–5435.0). Initial volunteers included members of the design and testing team, and written consent was obtained for all volunteers prior to participation in the study.

Statistical analysis

Data analyses were performed using Stata statistical software (Version 14.0, StataCorp, College Station, TX, USA), and visual data representations were created using the R package ggplot (RStudio 2020, Boston, MA, USA). The seven separate maneuvers were categorized into three stationary and four dynamic maneuvers, and the non-parametric Kruskal-Wallis equality of populations rank test was used to compare differences in the harmonic mean fit-factors between stationary and dynamic runs to identify at which points the wearer is at risk of failure. The harmonic mean was as used by the Occupational Safety and Health Administration to represent the overall fit-factor from individual maneuvers [16]; similarly, harmonic means of the three stationary and four dynamic maneuvers were calculated and used in statistical comparison. Median scores and logarithmic scales were used to compare large ranging numbers where appropriate.

Results

The filtration system testing results of different mask-filter configurations are summarized in Table 1. None of the cartridge design mask (Fig 1) and filter system combinations tested achieved targeted filtration counts of < 20 / cm3. Filtration counts ranged from ~ 1200 to 3500 / cm3 for the SFM mask cartridge (Fig 1) containing 3M5N11 filters. Seal resistance ranged from –1.0 kPa for the SFM mask with 3M5N11 2-ply to– 4.2 kPa for a sewn mask composed of Halyard 400 2-ply. An effective seal pressure of a respirator would be less than– 250 kPa. The testing revealed that the resistance of the small cross-sectional area of filters led to significant flow acceleration through minor leaks around the filter, filter cartridge, and mask-seal, resulting in poor performance. In response to these results (Table 1), we decided to use off-the-shelf medical grade respiratory HME filters with known pressure drop properties and greater than N95 filtration efficiency [17]. The focus then became adequacy of filter adapter seal and mask body seal. For this purpose, silicone or soft rubber were considered leading candidates, given their biosafe nature and industrial usage of these materials in seals of commercial respirators [18].

The resultant SSM prototype was a unibody, simple silicone mask with a single port for attachment of universal sized (22mm - 15mm od) adapters, including the respiratory filter (Fig 13). The SSM alone weighed ~155 g. There was no loss of content after overnight decontamination by soaking in 1:10 5.25% sodium hypochlorite (Chlorox™) bath and subsequent water rinsing. The circular top of the harness sat over the central port of the SSM body, allowing attachment of the filter adapter. Two elastic straps ~ 50 cm in length and 6 mm wide) were secured to the harness by looping the ends through the two harness gaps. The narrower (15 mm end) adapter port of the HME filter was then inserted into the central port. A Glia (https://glia.org) face shield was worn over the mask to check overall fitting with this additional personal protective equipment (Fig 14). The individual in Fig 14 has given written informed consent (as outlined in the PLOS consent form) to publish this case detail.

Fig 14. The SSM respirator is worn with a face shield.

Fig 14

QNFT performance during preliminary validation

The results from preliminary testing on HCWs were rapidly reported back to R&D team for analysis and refinement of design. Different respiratory HME filters were initially tried until a suitable size was determined and supply secured. DAR™ pediatric | adult mechanical filter (Medtronic, Kirkland, QC), Intersurgical Hydro-Mini™, Intersurgical Air-Guard™ (Intersurgical, Burlington, ON) were trialed at this stage. Comfort and breathability scores were also recorded out of five. Once preliminary fit-factor scores were stable, the team settled on the SSM prototype as described in this report for further subject QNFT (Fig 13).

Preliminary QNFT was performed on eight different volunteers, including three authors (VA, WN, AM). Seven runs were performed on each wearer according to CSA Z94.4–18 protocol. Fit-factors for each maneuver and each prototype iteration are presented in Table 3. The median overall fit-factor was 1662. Overall, seven out of eight tests passed. The first preliminary fit-test on the first prototype scored 108 for the overall fit-factor, but failed the runs of turning side-to-side (93), talking (83), and bending (92). The filter used was a ~ 6 x 4 x 3.5 cm3 pleated HME filter Intersurgical Hydro-Mini™. The next two preliminary tests were performed on different volunteers using the second prototype, which had adjusted nasal bridge silicone padding when compared to the first prototype, as that was determined to be the source of minor tearing and leakage in the first prototype. Prototype 2 was paired with a DAR™ pediatric | adult mechanical filter (labeled DAR™ small in Table 3), which is of similar dimension to the previous HME filter, but from a different manufacturer. These fit-tests scored 199 and 308 overall and passed each of the seven runs.

Table 3. Results for SSM prototype fit-tests (n = 8).

Run 1 Run 2 Run 3 Run 4 Run 5 Run 6 Run 7 Overall fit-factor Filter SSM type
1 196 118 93 127 83 92 104 108 Hydro-Mini™ I
2 429 229 215 213 113 161 250 199 DAR™ small II
3 363 273 580 273 219 293 344 308 DAR™ small II
4 >106 25959 10240 16958 4235 2675 >106 8695 Air-Guard™ III
5 >106 10702 >106 21075 2467 12724 18987 10332 Air-Guard™ III
6 11144 7762 8717 7422 390 3131 8338 2018 Air-Guard™ III
7 17210 7457 53252 57044 1133 61843 >106 6212 Air-Guard™ III
8 1556 1536 1051 1621 1369 1321 994 1307 Air-Guard™ III

I–SSR MB-ON with nasal deficiency; II–SSM prototype with nasal bridge fix; III–SSM prototype with nasolabial pad adjusted.

In addition, volunteer anthropometrics, gender, BMI have been included in S1 Table.

At this stage, prototype 3 was tested on five more volunteers outside of the core team. Prototype 3 had less of a nasal vertex and more of a rounded nasal bridge rim. The nasolabial curvature was adjusted according to wearer feedback to better fit the actual fold-contour. The filter used was an Intersurgical Air-Guard™ filter, measuring ~ 6 x 8 x 3.5 cm3 and almost double the effective surface exchange area of a Hydro-Mini™ filter. The lowest overall fit-factor was 1307. It was noted that in seven of the eight fit-tests, Run 5 (talking), scored the lowest for each test. In summary, seven out of the eight preliminary fit-tests passed according to the CSA protocol for N95 respirators (Fig 15). Comfort and breathability scores were 3.7 and 3.6 out of 5 respectively. The Intersurgical Air-Guard™ attached to the SSM was subjected to a NaCl permeability test regimen, 42 CFR Part 84 (at 30 L/min) [11], for filtration efficiency as a function of particle mass. The filtration efficiency was 99.7%, at a pressure drop of– 0.21 kPa.

Fig 15. Heatmap of SSM Prototype Fit-Tests (n = 8).

Fig 15

The boxplot of the log10 transformed composite fit-factors across all 8 volunteers are represented in Fig 16. The median composite fit-factor was 3400 (3.5 on log scale) and 1293 (3.11 on log scale) for stationary and dynamic maneuvers respectively, but this difference was not statistically significant (p = 0.2936, Kruskal-Wallis equality of populations rank test).

Fig 16. Boxplot of composite fit-factors across stationary vs. dynamic maneuvers.

Fig 16

Boxplot of stationary and dynamic Log10(Harmonic mean) fit-factors. The box represents the interquartile range (Q1—Q3) and the band within the box is the median. Outliers were defined as lying outside the range defined by interquartile range (IQR) +/- 1.5 IQR. The whiskers are located at the maximum and minimum values (excluding outlier denoted by “a”, i.e. Subject 5).

Discussion

The urgent need to address depleting RPD (respiratory protective device) supplies is clear. In May 2020, Canada cut its annual order of N95 masks by 50 M from 154.4 M because of supply shortage; only 1.7 M of 11.5 M N95 respirators the Canadian government has received in 2020 have passed quality control testing [19]. The continuous high demand for N95s has generated an upsurge of respirator prices. This can prevent underprivileged communities from accessing crucial PPE with adverse effect on disease transmission.

In response, researchers have attempted to develop reusable respirators to replace disposable N95s [20]. However, few novel respirators have been assessed by QNFT on HCW. This study describes the manufacture of a stopgap reusable respirator at the cost of CAD $15 for materials and 20 min of labor after initial investment in low-cost distributed manufacturing infrastructure and training of manufacturing personnel. We have used a standardized preliminary assessment of volunteer anthropometrics, user seal checks and validation by QNFT. This same methodology has been validated in our group’s paper in forty subjects [21]. The authors have arrived at an investigational reusable mask design that serves as the body for N95 equivalent stopgap respirators. With further evaluation, this novel half face-piece respirator may be implemented in case of supply chain disruption during the outbreak of COVID-19, with the proviso of availability of equipment, materials, and trained personnel (see below). The wearing of facemasks is a supplementary approach to reduce disease spread in addition to physical distancing measures and hand hygiene [22].

The design simplification into two crucial challenges helped the team to firstly aim for achievable immediate gains (reusable mask body), and secondly develop future solutions to more difficult challenge of manufacturing filter materials. The particle filtration efficiency testing revealed that simple cartridge-style mask with replacement filters would not be adequate, not due to limitations of the filtering material but because of consistent difficulties in ensuring a reliable seal around the filter casing. Applying N95 grade filters of small effective surface area (~ 4 x 4 cm2) exaggerated seal leaks (seen in the low seal resistance measures, Table 1), and decreased overall performance (high particle count, Table 1).

With the described mask and filter combination, which utilizes known pleated-membrane HME filters with large cross-sectional areas for gas exchange, not only were the wearers able to breathe adequately, but the QNFT confirmed effective filtration efficiency or low particle counts within the respiratory chamber. In preliminary QNFT, the median fit-factor was 1662. To give a reference range, a fit-factor of 100 approximates 99% filtration efficiency, and 1000 ~ 99.9% [23]. Once again, the SSM with pleated HME filters reached overall fit-factors of over 100, even with the smaller sized pleated-membrane filters.

There are some strengths to the use of silicone such as its inert nature, biosafety, and flexibility that gives the SSM adequate seal. In terms of comfort, the SSM prototype received positive feedback and subjective scores. Hines et al. have argued for uptake of reusable elastomeric masks in the hospital setting during a pandemic-level of demand for RPDs [1]. Any reusable material (such as thermo plastic polyurethane TPU) when shaped and formed to seal a variety of faces can be considered for local groups wishing to reproduce these models. Silicone can provide seal to tubular adapters, which can be tailored to fit various available commercial filters.

3D printing technology, originally developed as a prototyping technique, is being used increasingly for small to medium scale production in agriculture, healthcare, automotive industry, and aerospace industries [24, 25]. 3D printing is also increasingly used in low- and middle-income countries. Combined with other low-cost manufacturing techniques, such as silicone casting, such systems can provide the capacity to rapidly address immediate local needs during acute emergencies and supply chain disruptions [26]. At the time of this writing, a neighboring independent group (McMaster University, Hamilton, CA) has reproduced a workable batch of SSM within 3 weeks and is currently performing subject-testing. This stresses the need to disseminate workable and simple solutions such as the one described in this paper promptly.

Disinfection and decontamination protocols are well documented for reuse of elastomeric masks. Possible methods for decontamination cited by the CDC were vaporous hydrogen peroxide, ultraviolet germicidal irradiation, and moist heat [27]. In the hospital setting, available options include hydrogen peroxide vapor phase decontamination and autoclaving at high heat [1]. However, as per CDC instructions, solvents (e.g., acetone, ethanol) and high heat (greater than 50°C) should not be used to disinfect elastomeric respirators [20]. In our case, each component of the respirator was disinfected separately (excluding the filter containing cartridge) prior to and after each testing. The respirator body, harness and straps were disinfected using a diluted household bleach solution (5.25% sodium hypochlorite) as recommended by the CDC [20]. To prepare the solution, ~ 180 mL of household bleach was added to 3.8 L of water. The respirator components were submerged in the solution for 5 minutes, then rinsed with tap water. The components were then air-dried in a well-ventilated area prior to use. We did not reuse cartridges between volunteers; the extent of cartridge reusability (outside the scope of this study) was not investigated. The reusability of the silicone respirator body, harness and elastic straps was tested by disinfection of each component up to 50 times consecutively, with preserved integrity after 50 cycles of disinfection. The concept of a personal reusable mask could be appealing to users, and such ownership requires ease of decontamination methods such that HCWs outside of healthcare settings can easily manage their masks. The use of household bleach as recommended by the CDC was a feasible and affordable method of disinfection.

Limitations

The current described option is reusable only to the extent of the mask body, harness, and straps. The HME filters themselves are not reusable to the same degree but their use can be prolonged. The HME filter instalment to the SSM forms both the inflow and outflow to respiration and is exposed to the wearer’s droplets. Condensation and heat build-up will eventually occur over long periods of use (hours over days). HME filters will need to be dried after use, in a disaster scenario, prior to reuse. Any excess soiling to the filter casing will require a filter change. Given the relative lower cost of the filters tested compared to disposable respirators (approximately CAD $3 vs. CAD $6) [17, 28], there is still an economic and environmental argument to reusing minimal number of components, and for the prolongation and decontamination of disposable parts-to-wholes. In ICU settings, typically respiratory HME filters would be changed after one day of continuous use [17]. Given the use of Air-Guard™ filters in a stopgap respirator is technically off-label, each provider group must provide their own protocol for safe duration of usage. Further research is required to evaluate filter durability and contamination (by bacterial and fungal growth sampling for example) after prolonged use.

Aesthetic and pragmatic human performance considerations are equally important including comfort and breathability. We recommend institutional field-testing to inform further modifications to maximize the acoustic quality, weight-reduction, and interaction with goggles, glasses and face-shields. The RPD is a part of the PPE armament, and must be optimized to co-fit with other protective devices. Silicone is also acoustically absorbent compared to PETG or TPU 3D printing filaments. A hybrid body that utilizes both TPU and silicone seal would increase audibility. The team has not quantified the acoustic quality of the mask-wearer at this stage of preliminary testing.

The sample size of the preliminary testing is small (n = 8) and is not enough to represent the HCW population of facial type ranges. There is no reference to the baseline performance of the respectively assigned disposable N95 respirator in the volunteers. At the time of writing, a larger comparative subject-validation trial was initiated to investigate the SSM performance [21] for a representative group of HCWs and gauge whether it was an equivalent N95 respirator.

This present report has taken a hybrid approach in addressing both the concerns of fit-testing validation for acute care clinical leadership audience, and also understanding the design and development background to an example of local-manufactured silicone-based respirator body with pleated-membrane filters. It is challenging for a specialty team to pivot sufficiently to gain expertise in all parts of this prototype development. Local leaders will need to assemble a multidisciplinary team consisting of occupational health, biomedical engineering, design, and clinical experts in order to replicate or adapt reusable respirators like the SSM. But we are publishing our experience with the expectation that the major steps outlined in this report will make reproducibility and local adoption easier.

Respiratory protection devices including half-face elastomeric respirators for use in a workplace setting including the healthcare setting must have approval from appropriate regulatory agencies, viz. NIOSH certification as per Ontario Reg 185/19 sec.10(1) under the Occupational Health and Safety Act. Therefore, The Lynn and Arnold Irwin Advanced Perioperative Imaging Lab (APIL) and its affiliates do not endorse the use of the stopgap respirator described above until such time as additional testing and regulatory approval have been obtained. This half-face respirator as described is an investigational device under development and has not passed all relevant tests for safety and effectiveness and does not currently meet all regulatory requirements for respirators in Canada.

Conclusion

The challenge to PPE and respiratory protective device supply will continue given the state of the COVID-19 pandemic. Respirators of N95 grade will be in demand in the foreseeable future. The production by distributed manufacturing has the advantage of access, low-cost, reusability, and reliability in supply. We have described the process of arriving at a reusable N95 grade respirator using a simple reiterative design and production process, off-the-shelf HME filters, 3D printing and silicone casting. The SSM prototype is only one of many options that can potentially be reproduced and tailored to meet the local and regional HCW respirator needs. Regulatory requirements must be met before RPDs are to be used in the non-emergent setting. Lastly, the need for larger subject validation and field-testing of such reusable respirators is taxing but worthwhile given the stakes and benefits of prolonged respirator reusability in a protracted pandemic course.

Supporting information

S1 Table. Demographics and anthropometric characteristics of participants.

(DOCX)

S1 File. 3D Print settings and silicone casting process.

(DOCX)

S2 File. De-identified dataset N8.

(XLSX)

Acknowledgments

The authors sincerely thank the UHN Department of Anesthesiology, The Lynn and Arnold Irwin Advanced Perioperative Imaging Lab, and The Toronto General and Western Hospital Foundation for their academic support. Thanks to Christian Petropolis (University of Manitoba), Thomas Looi (SickKids CIGITI), Brandon Peel (SickKids CIGITI), and Matt Ratto (Faculty of Information, University of Toronto UofT) for their concept, design, and production input. We are grateful for the pro bono printing provided by Steve Cory (Objex Unlimited, Mississauga, Canada), James Garel-Jones (Vertigro, Toronto), and Brian Read (Coburg, Canada). Thanks to James Scott et al. at the Gage Lab, Occupational Environmental Health, University of Toronto for their filtration testing. Intersurgical (Michael Hayden, Burlington, Canada) was most generous in donation of respiratory filters. The Techna Institute (Toronto) provided vital laboratory space amidst the UHN COVID response. Thanks to Chris Murray, Lakehead University (Orillia, Canada), for filter material testing, and Andre Lafreniere (Thunder Bay, Canada) for design input. The Toronto Emergent Device Accelerator platform, 3D-PPE-GTHA, Kingston PPE, NOSM PPE, and USASK PPE groups (Canada) provided important student and faculty networks and bolstered the design process. Thanks to Alana Bernick (UofT) for proof-reading from an occupational health perspective. Final thanks belong to Andrew Syrett (MD, McMaster University), Nasa Nguyen and Natasha Valenton (BAScEng, University of Toronto), without whose design and creativity the respirator development could not have started and progressed to a stopgap solution.

Data Availability

Data will be available on repository https://github.com/tgh-apil/Reusable-N95-Respirator/blob/master/10-Publication/PLOS_manufacturing_deidentified_12.15.2020.xlsx.

Funding Statement

The authors received no specific funding for this work.

References

Decision Letter 0

Tommaso Lomonaco

11 Dec 2020

PONE-D-20-21977

Development, manufacturing, and preliminary validation of a reusable half-face respirator during the COVID-19 pandemic

PLOS ONE

Dear Dr. William C. K. Ng,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by 21th December 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Tommaso Lomonaco, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please clarify in your Ethics statement and Methods section the full name of the ethics committee that approved the study, along with the approval number. Please also clarify how the the participants gave consent.

3.Thank you for stating the following financial disclosure:

 [No].

At this time, please address the following queries:

  1. Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

  2. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

  3. If any authors received a salary from any of your funders, please state which authors and which funders.

  4. If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Please ensure that you refer to Figure 3 in your text as, if accepted, production will need this reference to link the reader to the figure.

5.We note that Figure [9] includes an image of a patient / participant in the study. 

As per the PLOS ONE policy (http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research) on papers that include identifying, or potentially identifying, information, the individual(s) or parent(s)/guardian(s) must be informed of the terms of the PLOS open-access (CC-BY) license and provide specific permission for publication of these details under the terms of this license. Please download the Consent Form for Publication in a PLOS Journal (http://journals.plos.org/plosone/s/file?id=8ce6/plos-consent-form-english.pdf). The signed consent form should not be submitted with the manuscript, but should be securely filed in the individual's case notes. Please amend the methods section and ethics statement of the manuscript to explicitly state that the patient/participant has provided consent for publication: “The individual in this manuscript has given written informed consent (as outlined in PLOS consent form) to publish these case details”.

Please respond by return e-mail with an amended manuscript. We can upload this to your submission on your behalf.

If you are unable to obtain consent from the subject of the photograph, please either instruct us to remove the figure or supply a replacement figure by return e-mail for which you hold the relevant copyright permissions and subject consents. In some cases, you may need to specify in the text that the image used in the figure is not the original image used in the study, but a similar image used for illustrative purposes only. We can make any changes on your behalf.

6. Please ensure that your related published work https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242304 is referenced within the manuscript.

Additional Editor Comments:

Dear Authors,

please find attached the reviewers' comments. Please answer in details all the questions raised during the revision process.

Best regards.

Tommaso Lomonaco

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a very timely and well-written manuscript. Essentially, the research team has developed a reusable silicone half-facepiece respirator that can be used when there are supply challenges with existing respiratory protection used in healthcare e.g. N95 respirator for airborne diseases including COVID-19.

One of the major shortcomings of the study is that the authors only conducted testing of the respirator on eight different volunteers. This is a small number to begin with and the authors have acknowledged that this is a study limitation. However, in order to strengthen their study, they should, in my opinion, include the gender, weight and anthropometric dimensions of each volunteer’s face to ascertain if they are typical of respirator users such as the article by Zhuang and Bradtmiller (2005) Head-and-face anthropometric survey of US respirator users. Journal of occupational and environmental hygiene 2(11):567-76. This is important because commercially-available respirators come in different shapes and sizes and it would behoove the research team to include this information so that the reader is confident that the novel respirator is suitable for his/her workforce.

Upon review of the research team, there does not appear to be anyone with a formal background in occupational hygiene or occupational health and safety. This has resulted in some obscure terminology and/or errors. For instance, in the abstract, the team uses the phrase “user pressure test” which is commonly referred to as “user seal check” among the occupational health and safety community.. Also, on line 126 under “Methods”, NIOSH is the acronym for the “National Institute for Occupational Health and Safety” (the authors used “of” instead).

Lastly, but most importantly, I am not sure if the research team is aware that any respiratory protection selected for use in a workplace must meet approval requirements e.g. NIOSH-certified as per Ont. Reg 185/19 sec.10(1) under the Occupational Health and Safety Act (this legislation was selected because the authors are based in Ontario, Canada). Given that this is a legal requirement, I believe that the authors should explicitly have a statement regarding this matter in their manuscript (such as in the abstract as well as in the Discussion). Despite the promise of their novel respirator, it cannot technically be used in a workplace without the device being certified first.

Given the above, I therefore urge the team to consider seeking an expert in occupational health and safety to ensure that terminology and statements within their manuscript is correct.

In the Methods section, there is no mention about institutional ethics. Since human subjects were involved, it is assumed that research ethics is required. The authors should provide clarity on this.

In the Methods section. No justification or basis for conducting differences in the median harmonic mean fit-factor is provided i.e. there is no reference cited for this test e.g. CSA Z94 and/or another published study. The authors should provide clarity on this.

In the Discussion section, the authors stress the importance of disinfection and decontamination of reusable elastomeric masks. However, the authors did not actually test the feasibility of disinfection and reuse of their novel respirator (not to mention how many times the mask mold can be disinfected before the integrity becomes questionable). This should be mentioned as a limitation to their study because the ability to reuse a protective device is incredibly important.

In Figure 9, the worker is wearing a face shield in addition to the novel respirator. Have the authors tested additional protective equipment such as goggles/safety glasses as well as a combination of face shield and goggles/safety glasses with the respirator? The authors should provide clarity on this.

In the Methods section, the sub-section related to “Model 2” is extremely technical. I am not sure who the intended audience is but it would be really helpful for a reader if this could be simplified somewhat so that they will be able to replicate the respirator within their own organization. Also, please define all acronyms the first time they are used e.g. PLA and PETG.

Reviewer #2: This is a very topical and useful paper in this pandemic and for the future. So it needs publication. It will add prestige to the journal, I suggest mandatory revisions and re-review:

1. Recent overarching specific literature is not covered and related to this work, see a very original paper on masks related to this pandemic by Ahmed et al in Med Devices & Sensors. Also, a very case specific paper very relevant to this work by Alenezi et al. in BioDesign & Manufacturing. Discuss your work in relation to these.

2. There has to be more evaluation in terms of discussion and statistics on the manufacturing of this device. Is it cost-effective?

3. Particles passed (Table 1) re-check and give in whole numbers, more stats required.

4.Figs 4-7 and may be 8 too come in quick succession, more discussion required here.

5." Fit-factor of over 100 is a pass." - ??? Explain more. Units are all over the place, USE SI units only in entire manuscript.

6. "3D printing is now commonly available to community groups and almost all countries

including middle-income countries. The use of affordable, low-cost 3D printers will allow users

to rapidly print molds. " - needs more evidence and discussion as I said before (under 2), manufacturing is a key factor.

7. Scales needed in all figures.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 17;16(3):e0247575. doi: 10.1371/journal.pone.0247575.r002

Author response to Decision Letter 0


7 Jan 2021

This is a copy of the new cover letter to the Editor and the Reviewers.

"Dr. Tommaso Lomonaco, Ph.D

Academic Editor

PLOS ONE

Toronto, Dec 18th, 2020

RE: Response to Reviews of “Development, manufacturing, and preliminary validation of a reusable half-face respirator during the COVID-19 pandemic”

ID: PONE-D-20-21977

Dear Dr. Tommaso Lomonaco, Reviewer1, and Reviewer 2,

Thank you all for your time in reviewing the submission. The editorial and review comments are invaluable and are addressed sequentially, as outlined in the decision letter “PONE-D-20-21977 Decision Major Revision 2020 Dec 11”

1. The MS and supporting files has been edited and renamed to meet PLOS ONE requirements.

2. The full name of the ethics committee which approved the study has been included in the Methods section (University Health Network, Research Ethics Board). The approval number has also been included (REB# 20-5435.0). Written consent was obtained for all volunteers in the study. This has been added in the Methods section as well.

3. Regarding funding and salary:

a, b, d. The authors received no specific funding for this work.

c. The authors received no funding nor salary for this work.

Thank you for changing the online submission form on our behalf.

4. Figure 3 has been referred to in the MS text.

5. The image in Figure [9] is of the first author (Vahid Anwari) listed in MS. The author has downloaded the Consent Form, has signed and filed the case notes.

The following text has been added to the Methods section, after Figure 9, to comply with PLOS ONE guidelines: “The individual in Figure 9 has given written informed consent (as outlined in the PLOS consent form) to publish this case detail.”

6. The authors’ related published work has been referenced in the MS test: (https://journals.plos.org/plosone/articleid=10.1371/journal.pone.0242304).

7. We have added the raw testing dataset into a supporting file.

8. We have added more statistical explanation as suggested by the reviewers.

Response to Reviewer 1 and 2’s comments:

Thank you for the detailed comments, they were instructive, provided valid criticisms and pointed out areas of improvements to the MS:

Reviewer #1: “This is a very timely and well-written manuscript. Essentially, the research team has developed a reusable silicone half-facepiece respirator that can be used when there are supply challenges with existing respiratory protection used in healthcare e.g., N95 respirator for airborne diseases including COVID-19.”

• Thank you for the encouragement.

“One of the major shortcomings of the study is that the authors only conducted testing of the respirator on eight different volunteers. This is a small number to begin with and the authors have acknowledged that this is a study limitation. However, in order to strengthen their study, they should, in my opinion, include the gender, weight and anthropometric dimensions of each volunteer’s face to ascertain if they are typical of respirator users such as the article by Zhuang and Bradtmiller (2005) Head-and-face anthropometric survey of US respirator users. Journal of occupational and environmental hygiene 2(11):567-76. This is important because commercially-available respirators come in different shapes and sizes and it would behoove the research team to include this information so that the reader is confident that the novel respirator is suitable for his/her workforce.”

• We have added the gender, weight and anthropometric dimensions of each volunteer in a table format and referenced it within the MS text. This is a welcomed comment.

“Upon review of the research team, there does not appear to be anyone with a formal background in occupational hygiene or occupational health and safety. This has resulted in some obscure terminology and/or errors. For instance, in the abstract, the team uses the phrase “user pressure test” which is commonly referred to as “user seal check” among the occupational health and safety community. Also, on line 126 under “Methods”, NIOSH is the acronym for the “National Institute for Occupational Health and Safety” (the authors used “of” instead).”

• The NIOSH’s expanded title has been rectified.

• All references to “user seal check” has been rephrased as such.

Lastly, but most importantly, I am not sure if the research team is aware that any respiratory protection selected for use in a workplace must meet approval requirements e.g. NIOSH-certified as per Ont. Reg 185/19 sec.10(1) under the Occupational Health and Safety Act (this legislation was selected because the authors are based in Ontario, Canada). Given that this is a legal requirement, I believe that the authors should explicitly have a statement regarding this matter in their manuscript (such as in the abstract as well as in the Discussion). Despite the promise of their novel respirator, it cannot technically be used in a workplace without the device being certified first.

• The following issue is now extensively addressed in the Limitations section, with specific reference to the Ontario Reg 185/19 sec.10(1) under the Occupational Health and Safety Act. The need for further testing in order to meet regulatory requirement and the non-endorsement of the described investigational device is stated.

• The following text has been added in the abstract’s conclusion: ‘The product described above is an investigational device and does not currently meet regulatory requirements for a respirator. Therefore, the authors and/or any affiliates do not make any endorsements for the use of products described above.’

“Given the above, I therefore urge the team to consider seeking an expert in occupational health and safety to ensure that terminology and statements within their manuscript is correct.”

• An OH and Biomedical Colleague has been invited to read the final submission for this express purpose.

“In the Methods section, there is no mention about institutional ethics. Since human subjects were involved, it is assumed that research ethics is required. The authors should provide clarity on this.”

• Our apologies in not clarifying institutional ethics approval, thank you for pointing out. The full name of the ethics committee which approved the study has been included in the Methods section (University Health Network, Research Ethics Board). The approval number has also been included (REB# 20-5435.0). Written consent was obtained for all volunteers in the study. This has been added in the Methods section as well.

“In the Methods section. No justification or basis for conducting differences in the median harmonic mean fit-factor is provided i.e. there is no reference cited for this test e.g. CSA Z94 and/or another published study. The authors should provide clarity on this.”

• Firstly, the formula for the overall fit-factor is a harmonic mean, given by the formula Overall Fit-Factor = No. Runs (N) / (1/ff1 + 1/ff2 + 1/ff3 + … +1/ffN),

where N = 7 for QNFT per CSA Z94.4-18 and OHSA of the USA (see Reference 15).

• Looking at the range of overall fit-factors (108 to 10332), we decided to use a median for such skewed raw data. Log transformation has been used also where appropriate.

“In the Discussion section, the authors stress the importance of disinfection and decontamination of reusable elastomeric masks. However, the authors did not actually test the feasibility of disinfection and reuse of their novel respirator (not to mention how many times the mask mold can be disinfected before the integrity becomes questionable). This should be mentioned as a limitation to their study because the ability to reuse a protective device is incredibly important.”

• The disinfection and cleaning protocol for the respirator has been added in the Discussion.

“In Figure 9, the worker is wearing a face shield in addition to the novel respirator. Have the authors tested additional protective equipment such as goggles/safety glasses as well as a combination of face shield and goggles/safety glasses with the respirator? The authors should provide clarity on this.”

• Yes partially: indeed in preparation for the Figure as well in practice runs, we have worn face-shields on top of the mask prototype. We have not applied goggles in every test run on top of the mask. But we have been able to apply the volunteer’s own spectacles as they would normally wear on top of the mask. This has been clarified in the discussion.

“In the Methods section, the sub-section related to “Model 2” is extremely technical. I am not sure who the intended audience is but it would be really helpful for a reader if this could be simplified somewhat so that they will be able to replicate the respirator within their own organization. Also, please define all acronyms the first time they are used e.g. PLA and PETG.”

• We have simplified “Model 2”’s technical subsection and moved the detailed version into a supporting file.

• We have expanded the TLA PLA and PETG in several places in the MS and the supporting file.

Response to Reviewer 2’s comments:

Reviewer #2: “This is a very topical and useful paper in this pandemic and for the future. So, it needs publication. It will add prestige to the journal, I suggest mandatory revisions and re-review:”

1. “Recent overarching specific literature is not covered and related to this work, see a very original paper on masks related to this pandemic by Ahmed et al in Med Devices & Sensors. Also, a very case specific paper very relevant to this work by Alenezi et al. in BioDesign & Manufacturing. Discuss your work in relation to these.”

• Thank you for these two references by Ahmed et al. and Alenezi et al. We have added a discussion of our work in relation to these two original papers and will add these to a 3rd follow-up paper to this one. (our group’s 2nd paper has been referenced and published in PLOS ONE Nov 2020)

2. “There has to be more evaluation in terms of discussion and statistics on the manufacturing of this device. Is it cost-effective?”

• Cost-effectiveness in terms of dollars per unit and hours of manual labor per unit has been added in the discussion section.

3. “Particles passed (Table 1) re-check and give in whole numbers, more stats required.”

• The “particles passed” column has been rechecked and given in whole numbers; but no additional relevant analysis added upon discussion with our statistical personnel for this column.

4. “Figs 4-7 and may be 8 too come in quick succession, more discussion required here.”

• We have now spread-out references to Fig 4-7 with discussion sentences placed in between.

5. “" Fit-factor of over 100 is a pass." - ??? Explain more. Units are all over the place, USE SI units only in entire manuscript.”

• Thank you for the suggestions. We have expanded the sentence on “fit-factor” to include each individual maneuver’s fit-factor and the overall fit-factor. Units are now in SI: where m, cm, mm, um, and nm are appropriate, we have used that for distance; inches of water are now expressed in kPa for pressure (we know that this breaks tradition with the pressure units in our two NIOSH references and some other referenced articles, but it is now internally consistent and easily translatable by the thorough reader).

6. “"3D printing is now commonly available to community groups and almost all countries including middle-income countries. The use of affordable, low-cost 3D printers will allow users to rapidly print molds. " - needs more evidence and discussion as I said before (under 2), manufacturing is a key factor.”

• We accept the comment that the two sentences require more evidence, and therefore we have rephrased the comment into an admission of need for further evidence of accessibility of equipment and manufacturing feasibility in middle-income countries.

7. “Scales needed in all figures.”

• We have added scales to figures.

We hope the major revision to the MS as indicated above has made this submission acceptable to PLOS, in line with the Journal’s rigorous academic standards. Thank you all once again for the reviews, comments and suggestions.

Truly,

William C. K. Ng

MBBS MMed FANZCA FRCPC

Anesthesia and Pain Management, Toronto General Hospital

TGH Research Institute & UHN Advanced Perioperative Imaging Lab

Pediatric Cardiac Anesthesia, SickKids Hospital

Faculty Dept. of Anesthesiology, University of Toronto

M 1.857.330.7399

E William.Ng@uhn.ca or William.Ng@sickkids.ca

Soli Deo Gloria"

Decision Letter 1

Tommaso Lomonaco

27 Jan 2021

PONE-D-20-21977R1

Development, manufacturing, and preliminary validation of a reusable half-face respirator during the COVID-19 pandemic

PLOS ONE

Dear Dr. William C. K. Ng,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by 9th February. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Tommaso Lomonaco, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Dear authors, all the questions raised during the revision process has been answered. Anyway, the article requires additional minor revisions.

Regards,

Tommaso Lomonaco

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have done an admirable job responding to the previous comments. However, there are still some matters that need to be addressed - see below. The other point that I want to bring to the attention of the authors is who, exactly, is the intended audience? I ask because there appear to be various disciplines addressed in the manuscript and, in my opinion, it would be a challenge for one discipline to understand and recreate all elements in the manuscript for their practice. In other words, it appears that someone knowledgeable in 3D printing wrote part of the ms, someone with occupational health background wrote other segments, and the statistically analyses was written by someone else entirely. Personally, this made it very hard for me to follow as a reviewer. I bring this forward because, since this manuscript is meant to have practical applications, it might be beneficial to explain which departments from an acute care facility need to be involved to produce these devices. (Perhaps this could be an entirely separate manuscript altogether?)

Page 4, line 75. Grammatical error. Word should be “affecting” not “effecting”

Page 4, lines 87-88. The statement is technically incorrect. N95 respirators are 95% effective in filtering aerosols around 0.3 μm (which is the most penetrating particle). This is not explicitly stated in the referenced Brosseau CDC blog - one needs to “read between the lines” but this is the normally accepted definition. See https://www.sciencedirect.com/science/article/pii/S2452199X20301481 and https://www.cdc.gov/niosh/docs/96-101/default.html as examples.

Page 5, line 94. Please define “SSM”.

Page 6, line 108. Grammatical error. Should be “designed” not “designs”.

Page 6, lines 123 - 124. Please provide a reference for the statement: “General purpose health care respirators must achieve 95% filtration of particles down to 10 nm”.

Page 9, Table 2. The authors have mentioned that producing the new device is cost effective and does not require much in terms of labour. However, in terms of development time in Table 2, it appears to be nearly 40 hrs per single respirator! If the primary objective of undertaking this study is to off-set supply shortages of PPE during a pandemic, then the development time needs to be discussed as this is a potential limiting factor especially in an acute care hospital where potentially hundreds of front-line care workers might require PPE.

Page 10, lines 192-193. I am unclear what this sentence means. “The design was iteratively modified and rested over 8 weeks”. Please clarify and/or elaborate…

Page 10, line 198. It should be “The Fit-testing device” not the “The Fit-tester device”.

Page 14, lines 271-274. Paragraph should be relocated to be the first paragraph after the subheading “QNFT performance during preliminary validation”.

Page 14, lines 279-280. Although I appreciate that the authors included anthropometric data, they really ought to compare their test subjects with anthropometric data of typical respirator users as per Zhuang and Bradtmiller (2005) Head-and-face anthropometric survey of US respirator users. Journal of occupational and environmental hygiene 2(11):567-76. This comparison is important to allow the reader to ascertain if the novel respirator would be suitable for his/her workforce.

Figure 03. Text is not clear in the red boxes.

S1 Table. What does “NIOSH Panel” refer to?

Reviewer #2: Sensible responses and revisions made. So, accept. The authors have given reasons for the changes. For easiness of review it would have been better if changes were highlighted in red on R1.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 17;16(3):e0247575. doi: 10.1371/journal.pone.0247575.r004

Author response to Decision Letter 1


29 Jan 2021

Dr. Tommaso Lomonaco, Ph.D

Academic Editor

PLOS ONE

Toronto, Jan 28th, 2020

RE: Response to 2nd Review of “Development, manufacturing, and preliminary validation of a reusable half-face respirator during the COVID-19 pandemic”

ID: PONE-D-20-21977R1

Dear Dr. Tommaso Lomonaco, Reviewer1, and Reviewer 2,

Thank you all for your time in reviewing the re-submission. The additional comments are now addressed sequentially, as outlined in the decision letter “PONE-D-20-21977 Decision Minor Revision 2021 Jan 27”

---

Dear Reviewer #1:

“The authors have done an admirable job responding to the previous comments. However, there are still some matters that need to be addressed - see below. The other point that I want to bring to the attention of the authors is who, exactly, is the intended audience? I ask because there appear to be various disciplines addressed in the manuscript and, in my opinion, it would be a challenge for one discipline to understand and recreate all elements in the manuscript for their practice. In other words, it appears that someone knowledgeable in 3D printing wrote part of the [MS], someone with occupational health background wrote other segments, and the statistically analyses was written by someone else entirely. Personally, this made it very hard for me to follow as a reviewer. I bring this forward because, since this manuscript is meant to have practical applications, it might be beneficial to explain which departments from an acute care facility need to be involved to produce these devices. (Perhaps this could be an entirely separate manuscript altogether?)”

- We agree that this is a major challenge for one discipline to understand and recreate all elements in the manuscript for local use. Without resorting to having a separate MS for the disparate 3D-printing elements alone, we want to keep the acute care audience’s primary focus on the validation and reiterative process of the prototype design, and secondarily allow the same non-expert audience to glean the major steps of the development and manufacturing background. This way, the recipient leader(s) can gauge what team members (such as biomedical engineering and design) and production hurdles would need to be overcome to successfully replicate this method, adapted to the local needs. We have added a standalone paragraph in the limitation section to draw attention to this hybrid aim. Page 21, lines 413-421.

“Page 4, line 75. Grammatical error. Word should be “affecting” not “effecting””

- Thanks, we have corrected this. Page 5, line 75.

“Page 4, lines 87-88. The statement is technically incorrect. N95 respirators are 95% effective in filtering aerosols around 0.3 μm (which is the most penetrating particle). This is not explicitly stated in the referenced Brosseau CDC blog - one needs to “read between the lines” but this is the normally accepted definition. See https://www.sciencedirect.com/science/article/pii/S2452199X20301481 and https://www.cdc.gov/niosh/docs/96-101/default.html as examples.”

- Thank you. We have rephrased the statement to be more accurate as suggested and added the first suggested reference by Tcharkhtchi et al. to point to this technical correction. Page 5, lines 87-88.

“Page 5, line 94. Please define “SSM”.”

- SSM is an assigned name of the respirator device, the derivation is now spelled out in the abstract. Page 6, line 94.

“Page 6, line 108. Grammatical error. Should be “designed” not “designs”.”

- This has been left as “design” because we are referring to the design object by Chris Richburg, not the action of Chris Richburg. Page 7, line 106.

“Page 6, lines 123 - 124. Please provide a reference for the statement: “General purpose health care respirators must achieve 95% filtration of particles down to 10 nm”.”

- In view of the suggestion to Page 4, lines 87-88, we have rephrased this to be consistent with the added reference to Tcharkhtchi et al.’s article and referenced to the same. Page 8, line 124.

“Page 9, Table 2. The authors have mentioned that producing the new device is cost effective and does not require much in terms of labour. However, in terms of development time in Table 2, it appears to be nearly 40 hrs per single respirator! If the primary objective of undertaking this study is to off-set supply shortages of PPE during a pandemic, then the development time needs to be discussed as this is a potential limiting factor especially in an acute care hospital where potentially hundreds of front-line care workers might require PPE.”

- Thanks for pointing this out. We have clarified development times and manual labor input times with the following comment to Table 2: “Development time of the mold and harness are the initial print times; when referred to the body, it is the silicone set-time. Labor time referred to in the abstract is the human hands-on time for pouring the silicone into the molds and assembly of the SSM.”

“Page 10, lines 192-193. I am unclear what this sentence means. “The design was iteratively modified and rested over 8 weeks”. Please clarify and/or elaborate…”

- We have elaborated on and clarified this sentence. Page 11, lines 194-195.

“Page 10, line 198. It should be “The Fit-testing device” not the “The Fit-tester device”.”

- We have changed the object reference as requested. Page 11, line 200.

“Page 14, lines 271-274. Paragraph should be relocated to be the first paragraph after the subheading “QNFT performance during preliminary validation”.”

- By Editorial stipulations, PONE have asked that this paragraph be moved even higher in the Methods section. Apologies for the editorial stylistic difference. Page 11, lines 225-228.

“Page 14, lines 279-280. Although I appreciate that the authors included anthropometric data, they really ought to compare their test subjects with anthropometric data of typical respirator users as per Zhuang and Bradtmiller (2005) Head-and-face anthropometric survey of US respirator users. Journal of occupational and environmental hygiene 2(11):567-76. This comparison is important to allow the reader to ascertain if the novel respirator would be suitable for his/her workforce.”

- Yes, we agree. This is a weakness that has been addressed in our discussion-limitations, and a larger sample of healthcare workers will need to be tested. The follow-up paper (published in PONE and referenced in the revised MS) looks at a larger representative sample of face types. Page 21, lines 405-409.

“Figure 03. Text is not clear in the red boxes.”

- We have used white background to the text to make it clearer.

“S1 Table. What does “NIOSH Panel” refer to?”

- The NIOSH Panel has now been spelt out and referenced under S1 Table. Thanks for alerting us of this internally used shorthand reference.

---

Dear Reviewer 2:

- Thanks once again for the encouragement. This MS with minor revisions should have highlights in color this time in the tracked version.

We hope the minor revisions to the MS as indicated above has made this submission acceptable to PLOS, in line with the Journal’s academic standards. Thank you all once again for efforts in improving this MS.

Truly,

William C. K. Ng

MBBS MMed FANZCA FRCPC

Anesthesia and Pain Management, Toronto General Hospital

TGH Research Institute & UHN Advanced Perioperative Imaging Lab

Pediatric Cardiac Anesthesia, SickKids Hospital

Faculty Dept. of Anesthesiology, University of Toronto

M 1.857.330.7399

E William.Ng@uhn.ca or William.Ng@sickkids.ca

Soli Deo Gloria

Decision Letter 2

Tommaso Lomonaco

10 Feb 2021

Development, manufacturing, and preliminary validation of a reusable half-face respirator during the COVID-19 pandemic

PONE-D-20-21977R2

Dear Dr. William C.K. Ng,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tommaso Lomonaco, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear Authors, all the questions were answered and thus I suggest to accept the manuscript.

Regards,

Tommaso Lomonaco

Acceptance letter

Tommaso Lomonaco

12 Mar 2021

PONE-D-20-21977R2

Development, manufacturing, and preliminary validation of a reusable half-face respirator during the COVID-19 pandemic            

Dear Dr. Ng:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Tommaso Lomonaco

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Demographics and anthropometric characteristics of participants.

    (DOCX)

    S1 File. 3D Print settings and silicone casting process.

    (DOCX)

    S2 File. De-identified dataset N8.

    (XLSX)

    Data Availability Statement

    Data will be available on repository https://github.com/tgh-apil/Reusable-N95-Respirator/blob/master/10-Publication/PLOS_manufacturing_deidentified_12.15.2020.xlsx.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES